Remimazolam Besylate Patent Expiration
Remimazolam Besylate is used for procedural sedation in adults undergoing short procedures. It was first introduced by Acacia Pharma Ltd
Remimazolam Besylate Patents
Given below is the list of patents protecting Remimazolam Besylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Byfavo | US10052334 | Dosing regimen for sedation with CNS 7056 (remimazolam) | Nov 07, 2031 | Acacia |
| Byfavo | US10195210 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Nov 07, 2031 | Acacia |
| Byfavo | US10342800 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Nov 07, 2031 | Acacia |
| Byfavo | US10472365 | Short-acting benzodiazepine salts and their polymorphic forms | Jul 10, 2027 | Acacia |
| Byfavo | US10722522 | Dosing regimen for sedation with CNS 7056 (remimazolam) | Nov 07, 2031 | Acacia |
| Byfavo | US10961250 | Short-acting benzodiazepine salts and their polymorphic forms | Jul 10, 2027 | Acacia |
| Byfavo | US9561236 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Apr 30, 2033 | Acacia |
| Byfavo | US9737547 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Nov 07, 2031 | Acacia |
| Byfavo | US9777007 | Short-acting benzodiazepine salts and their polymorphic forms | Jul 10, 2027 | Acacia |
| Byfavo | US9827251 | Dosing regimen for sedation with CNS 7056 (remimazolam) | Jan 13, 2034 | Acacia |
| Byfavo | US9914738 | Short-acting benzodiazepine salts and their polymorphic forms | Jul 10, 2027 | Acacia |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳